v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Mar. 31, 2025
Mar. 31, 2024
OPERATING ACTIVITIES:    
Net income $ 853,700 $ 855,422
Reconciliation of net income to net cash provided by (used in) operating activities:    
Depreciation and amortization 39,708 29,174
Stock-based compensation expense 230,840 156,547
Share of income from equity investee (2,053) (2,347)
Unrealized foreign currency exchange loss (gain) 2,742 (282)
Loss on extinguishment of convertible notes 30,251 0
Deferred income taxes, net (134,401) (144,485)
Other 5,577 3,186
Changes in operating assets and liabilities:    
Accounts receivable, net (including changes in related party balances of $5,878 and $4,363 during the nine months ended March 31, 2025 and 2024, respectively) 94,782 (501,870)
Inventories 457,897 (2,679,023)
Prepaid expenses and other assets (including changes in related party balances of $(2,782) and $(2,517) during the nine months ended March 31, 2025 and 2024, respectively) (284,356) (25,673)
Accounts payable (including changes in related party balances of $(49,991) and $13,448 during the nine months ended March 31, 2025 and 2024, respectively) (811,690) 309,613
Accrued liabilities (including changes in related party balances of $571 and $4,781 during the nine months ended March 31, 2025 and 2024, respectively) 52,714 123,937
Income taxes payable 5,365 (99,824)
Deferred revenue 249,421 132,043
Other long-term liabilities (including changes in related party balances of $729 and $(178) during the nine months ended March 31, 2025 and 2024, respectively) 5,414 5,424
Net cash provided by (used in) operating activities 795,911 (1,838,158)
INVESTING ACTIVITIES:    
Purchases of property, plant and equipment (including payments to related parties of $10,508 and $9,132 during the nine months ended March 31, 2025 and 2024, respectively) (104,536) (110,296)
Investment in equity securities 0 (27,673)
Net cash used in investing activities (104,536) (137,969)
FINANCING ACTIVITIES:    
Proceeds from lines of credit and term loans 1,357,991 1,818,850
Repayment of lines of credit and term loans (1,731,366) (1,939,590)
Proceeds from exercise of stock options 14,452 25,114
Payment for withholding taxes related to settlement of equity awards (118,960) (119,285)
Issuances of common stock in public offerings, net of issuance costs of $42,567 0 2,313,990
Payment of debt issuance costs (31,217) 0
Purchase of capped calls 0 (142,140)
Other 22 76
Net cash provided by financing activities 174,618 3,652,783
Effect of exchange rate fluctuations on cash 826 (1,634)
Net increase in cash, cash equivalents and restricted cash 866,819 1,675,022
Cash, cash equivalents and restricted cash at the beginning of the period 1,670,273 440,960
Cash, cash equivalents and restricted cash at the end of the period 2,537,092 2,115,982
Supplemental disclosure of cash flow information:    
Cash paid for interest 24,046 14,813
Cash paid for taxes, net of refunds 270,392 300,596
Non-cash investing and financing activities:    
Unpaid property, plant and equipment purchases (including due to related parties of $7,111 and $1,492 as of March 31, 2025 and 2024, respectively) 18,283 9,345
Right of use (“ROU”) assets obtained in exchange for operating lease commitments 128,617 24,140
Transfer of inventory to property, plant and equipment 4,889 0
Convertible Senior Notes Due 2029    
FINANCING ACTIVITIES:    
Payment of debt issuance costs (29,232)  
Proceeds from issuance of 2029 Convertible Notes, net of issuance costs of $31,217 Proceeds from issuance of 2028 Convertible Notes, net of issuance costs of $16,304 0 1,695,768
Convertible Senior Notes Due 2028    
FINANCING ACTIVITIES:    
Payment of debt issuance costs (16,304)  
Proceeds from issuance of 2029 Convertible Notes, net of issuance costs of $31,217 Proceeds from issuance of 2028 Convertible Notes, net of issuance costs of $16,304 $ 683,696 $ 0